Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPSAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DTNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCHCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf132 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TOM1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TJAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCBE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRNAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAMDC2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXorf36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724788 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C14orf105 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPRE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on